Hypertension data detailed by researchers at Yonsei University (evaluation of a drug management program targeting patients with hypertension and diabetes: impact on medication adherence): cardiovascular diseases and conditions – hypertension

2021 DEC 29 (NewsRx) – By a Journalist-Staff News Editor at NewsRx Cardiovascular Daily – Investigators publish new report on cardiovascular diseases and conditions – Hypertension. According to information from Incheon, South Korea, by NewsRx reporters, the research said: “The National Health Insurance Service of South Korea has conducted a telephone outreach program to improve treatment adherence in hypertensive and diabetic patients since 2014. Evaluate the direct results of the program.

Journalists obtained a research citation from Yonsei University, “Patients were identified among those who visited an outpatient clinic at least twice or used an inpatient department at least once for hypertension or diabetes at 6 month intervals and who were not adherents. on the basis of the calculated proportion of days covered (PDC). As a preliminary intervention, participants were mailed an information brochure on their own medication adherence and other tips for effective chronic disease self-management. For the intervention, two phone calls and three phone messages were made to patients by 24 participating regional offices. Ultimately, 2,428 hypertensive patients and 884 diabetic patients received the intervention. Propensity matching was used based on age, gender, and Charlson comorbidity index to select 12,140 hypertensive patients and 4,420 diabetic patients as controls in non-participating regions. The result was PDC. Multivariate ordinary least squares or logistic regression analysis were used with a difference-in-difference specification. Quarterly adjusted PDC increased 1.96% p for hypertension (p = 0.023) and 7.79% p for diabetic patients (p ratio = 1.157, 95% CI [1.058, 1.265]; diabetes: odds ratio = 1.532, 95% CI [1.323, 1.774]). The control group, which only received a printed intervention along with a leaflet mailed in, also showed a dramatic increase in treatment adherence.

According to reporters, the research concluded: “A telephone program coordinated by the insurer has improved treatment adherence in patients with hypertension and diabetes.

This research has been peer reviewed.

For more information on this research, see: Evaluation of a drug management program targeting patients with hypertension and diabetes: impact on medication adherence. Research in Social and Administrative Pharmacy, 2021; 17 (2): 419-427. Research in Social and Administrative Pharmacy can be contacted at: Elsevier Science Inc, Ste 800, 230, avenue du Parc, New York, New York State 10169, United States. (Elsevier – www.elsevier.com; Research in Social and Administrative Pharmacy – http://www.journals.elsevier.com/research-in-social-and-administrative-pharmacy/)

Our press correspondents point out that further information can be obtained by contacting Euna Han, Yonsei University, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, 162-1 Songdo Dong, Incheon 28560, South Korea. Additional authors of this research include Sunmee Jang, Hye min cho, Cinoo Kang, Hyun Soon Sohn and Ju-yeun lee.

The direct object identifier (DOI) for this additional information is: https://doi.org/10.1016/j.sapharm.2020.03.002. This DOI is a link to an electronic document online that is free or to purchase, and can be your direct source for a journal article and its citation.

(Our reports provide factual information on research and discoveries from around the world.)